ArticleFuture oncology (London, England)2025

NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: an open-label, phase II trial design.

Masafumi Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.